TLR2 and polyostotic fibrous dysplasia: This suggests that PFD may mitigate silicosis progression through modulation of TLR2-mediated NF-κB p50/p65 pathway activation, consequently reducing TNF and MMP9 production-two critical mediators of inflammatory response and extracellular matrix remodeling in pulmonary fibrosis.